Researchers from the Ruđer Bošković Institute will explore the frontiers of gene therapy and vaccine development through the "Integrative Characterisation of Novel adenovirus VECtors aimed at Therapeutic Applications" (INVECTA) project, thanks to a Marie Skłodowska-Curie Actions grant of nearly €200,000. The aim is to unlock the potential of uncommon adenoviruses with low levels of immunity for innovative treatments addressing critical medical gaps, delivering healing genes right where needed.

More than 100 participants gathered on a hybrid meeting at DESY on 14-15 March to officially kick-off the new EU project RIANA. RIANA (standing for Research Infrastructure Access in Nanoscience & Nanotechnology) has officially been launched on 01 March to offer access to Europe’s leading facilities in nanoscience and nanotechnology that are at the heart of the development of new materials for prosperity and sustainability.

A research team from the Ruđer Bošković Institute (RBI), led by Dr. Marin Roje, is participating in the COST project E-NICHE that aims to unify the diverse fields of chemical ecology, fostering cross-disciplinary research and innovation to explore the fascinating world of natural compounds to learn how life on Earth communicates through chemical signals.

In a new study, an international team of researchers, including scientists from the Ruđer Bošković Institute (RBI), has uncovered the critical role of viruses in Earth's methane cycle. Published in Nature Communications, this research signifies a major advancement in environmental science, elucidating the complex interaction between microorganisms, viruses, and greenhouse gases.

The oceans, often envisioned as vast blue expanses harboring the mysteries of the deep and unexplored ecosystems, are now closer to revealing their secrets thanks to the efforts of scientists involved in the SOUND project (Swarm of Underwater Noise Detectors).

In a groundbreaking move for the future of sustainable energy, the DONES Program has emerged as a pivotal player in the construction of next-generation fusion power plants, underscoring the united commitment of Croatia, Spain, and the international community towards advancing fusion technologies and materials.

The Ruđer Bošković Institute (RBI) has distinguished itself by achieving success in the highly competitive Horizon 2020 programme, the European Union's framework programme for research and innovation. This recognition comes as a result of the institute’s substantial contribution and outstanding performance in terms of both the number of projects applied for and successfully contracted.

The second DONES Steering Committee, the highest governing body of the DONES Fusion Programme, met in Granada on 26 October to review the progress of the programme, in particular the findings of the panel of independent experts who analysed the current state of the DONES baseline data.

Collaborative research led by Dr. Anamarija Brozović's team at the Ruđer Bošković Institute (RBI), in partnership with colleagues from the University of Zagreb, Vienna, Mainz, and Stanford, as well as the experts at Fidelta Ltd., has resulted in a significant advancement in the understanding of how ovarian cancer cells develop cross-resistance to the drugs typically administered for its treatment.